Patent · US Active

Treatment for cancers

US7763658B2 · kind B2 · utility

16Cited by

36References

6Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Keizo Koya · Sharon, US
Lijun Sun · Harvard, US
Yaming Wu · Shanghai, CN
Timothy Korbut · Watertown, US
Dan Zhou · Shanxi, CN
Zhenjian Du · Northborough, US
Shoujun Chen · Bedford, US
Noriaki Tatsuta · Lexington, US
Guiqing Liang · Concord, US
Mitsunori Ono · Lexington, US

Key dates

Filing date	Jan 15, 2004
Grant date	Jul 27, 2010
Priority date	—
Expiry date	Nov 14, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

One embodiment of the present invention is a method of treating a subject with a multi-drug resistant cancer. The method comprises administering to the subject an effective amount of a compound represented by Structural Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.